Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Community treatment orders (CTOs) have been widely introduced to address the problems faced by 'revolving door' patients. A number of case-control studies have been conducted but show conflicting results concerning the effectiveness of CTOs. The Oxford Community Treatment Order Evaluation Trial (OCTET) is the third randomised controlled trial (RCT) to show that CTOs do not reduce rates of readmission over 12 months, despite restricting patients' autonomy. This evidence gives pause for thought about current CTO practice. Further high-quality RCTs may settle the contentious debate about effectiveness.

Original publication




Journal article


Br J Psychiatry

Publication Date





406 - 408


Case-Control Studies, Commitment of Mentally Ill, Community Mental Health Services, Humans, Male, Middle Aged, Outcome Assessment, Health Care, Patient Compliance, Patient Readmission, Qualitative Research, Randomized Controlled Trials as Topic